US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

SPRC

SciSparc (SPRC)

SciSparc Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SPRC

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/31	20 : 17	GlobeNewswire Inc.	SciSparc Secures Strategic Advantage with Grant of European Patent	NASDAQ:SPRC	SciSparc Ltd
2024/04/11	21 : 15	GlobeNewswire Inc.	SciSparc to Acquire AutoMax	NASDAQ:SPRC	SciSparc Ltd
2024/03/21	21 : 58	GlobeNewswire Inc.	SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research	NASDAQ:SPRC	SciSparc Ltd
2024/03/18	20 : 29	GlobeNewswire Inc.	SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	NASDAQ:SPRC	SciSparc Ltd
2024/03/14	21 : 49	GlobeNewswire Inc.	SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial	NASDAQ:SPRC	SciSparc Ltd
2024/03/12	21 : 14	GlobeNewswire Inc.	SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	NASDAQ:SPRC	SciSparc Ltd
2024/03/08	23 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/03/08	21 : 11	GlobeNewswire Inc.	SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	NASDAQ:SPRC	SciSparc Ltd
2024/03/07	21 : 49	GlobeNewswire Inc.	SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	NASDAQ:SPRC	SciSparc Ltd
2024/03/07	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SPRC	SciSparc Ltd
2024/03/07	06 : 41	GlobeNewswire Inc.	SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology	NASDAQ:SPRC	SciSparc Ltd
2024/02/29	23 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/02/29	22 : 35	GlobeNewswire Inc.	SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing	NASDAQ:SPRC	SciSparc Ltd
2024/02/28	06 : 15	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:SPRC	SciSparc Ltd
2024/02/27	22 : 35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/02/27	21 : 58	GlobeNewswire Inc.	SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/27	21 : 58	GlobeNewswire Inc.	Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/21	06 : 27	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/02/20	21 : 14	GlobeNewswire Inc.	Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/20	21 : 14	GlobeNewswire Inc.	SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds	NASDAQ:SPRC	SciSparc Ltd
2024/02/13	06 : 27	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/30	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/29	21 : 18	GlobeNewswire Inc.	SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder	NASDAQ:SPRC	SciSparc Ltd
2024/01/25	23 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/24	21 : 42	GlobeNewswire Inc.	SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement	NASDAQ:SPRC	SciSparc Ltd
2024/01/22	20 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SPRC	SciSparc Ltd
2024/01/19	23 : 28	GlobeNewswire Inc.	SciSparc Advances the Acquisition Process of a Leading Vehicle Importer Company in Israel with the provision of a Bridge Loan of $1.4 million	NASDAQ:SPRC	SciSparc Ltd
2024/01/04	21 : 18	GlobeNewswire Inc.	SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments	NASDAQ:SPRC	SciSparc Ltd
2024/01/04	21 : 18	GlobeNewswire Inc.	Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments	NASDAQ:SPRC	SciSparc Ltd
2023/12/13	22 : 18	GlobeNewswire Inc.	SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform	NASDAQ:SPRC	SciSparc Ltd

Showing the most relevant articles for your search:NASDAQ:SPRC

1 2 3 4 5 6 7 次へ >>

American Express

Verizon Communications

US Dollar vs Yen

US Dollar vs Euro

Deutsche Telekom (QX)

Energy Select Sector SPDR

Bank of America

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約